Joint Filing Agreement
Exhibit 99.1
The undersigned hereby agree that this Statement on Schedule 13D dated January 9, 2023 with respect to the ordinary shares (the “Shares”) of Moolec Science SA is filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13(d)-1(k) under the Securities Exchange Act of 1934, as amended (the “Act”), and further agree that this Joint Filing Agreement be included as an exhibit to this Statement.
| Date: January 9, 2023 | ||
| BG FARMING TECHNOLOGIES LIMITED | ||
| By: | /s/ Xxxxxx Xxxxxxxx | |
| Xxxxxx Xxxxxxxx | ||
| Director | ||
| By: | /s/ Xxxxxx Xxxxxxxx Xxxxxxx | |
| Xxxxxx Montaron Xxxxxxx | ||
| Director | ||
| THEO I SCSP | ||
| By: | /s/ Xxxxxx Xxxxxxxx Xxxxxxx | |
| Xxxxxx Montaron Xxxxxxx | ||
| Attorney-in-Fact | ||
| BIOCERES GROUP PLC | ||
| By: | /s/ Xxxxxx Xxxxxxxx Xxxxxxx | |
| Xxxxxx Montaron Xxxxxxx | ||
| Attorney-in-Fact | ||
